
Publikationen von Matteo Pecoraro
Alle Typen
Zeitschriftenartikel (6)
1.
Zeitschriftenartikel
14 (1), 4632 (2023)
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification. Nature Communications 2.
Zeitschriftenartikel
117 (8), S. 4099 - 4108 (2020)
Role for ribosome-associated quality control in sampling proteins for MHC class I-mediated antigen presentation. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 3.
Zeitschriftenartikel
16 (4), e9247 (2020)
STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancer. MOLECULAR SYSTEMS BIOLOGY 4.
Zeitschriftenartikel
10, 1485 (2019)
Key Features Relevant to Select Antigens and TCR From the MHC-Mismatched Repertoire to Treat Cancer. Frontiers in immunology 5.
Zeitschriftenartikel
215 (1), S. 141 - 157 (2018)
Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy. Journal of Experimental Medicine 6.
Zeitschriftenartikel
36 (31), S. 4381 - 4392 (2017)
Delta Np63 alpha promotes adhesion of metastatic prostate cancer cells to the bone through regulation of CD82. Oncogene Meeting Abstract (1)
7.
Meeting Abstract
41 (Suppl. 4), S. 85 - 86. Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Wien, 28. September 2018 - 02. Oktober 2018. Karger, Basel (2018)
Spatial and temporal monitoring of neoantigen-specific T cells and T-cell receptors in a melanoma patient with secondary immune resistance to Ipilimumab. In Oncology Research and Treatment,